<code id='1C1348947C'></code><style id='1C1348947C'></style>
    • <acronym id='1C1348947C'></acronym>
      <center id='1C1348947C'><center id='1C1348947C'><tfoot id='1C1348947C'></tfoot></center><abbr id='1C1348947C'><dir id='1C1348947C'><tfoot id='1C1348947C'></tfoot><noframes id='1C1348947C'>

    • <optgroup id='1C1348947C'><strike id='1C1348947C'><sup id='1C1348947C'></sup></strike><code id='1C1348947C'></code></optgroup>
        1. <b id='1C1348947C'><label id='1C1348947C'><select id='1C1348947C'><dt id='1C1348947C'><span id='1C1348947C'></span></dt></select></label></b><u id='1C1348947C'></u>
          <i id='1C1348947C'><strike id='1C1348947C'><tt id='1C1348947C'><pre id='1C1348947C'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:comprehensive    Page View:9
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more
          Merck to acquire Harpoon Therapeutics for $680 million
          Merck to acquire Harpoon Therapeutics for $680 million

          MelEvans/APMerckannouncedMondayitwillacquireHarpoonTherapeuticsanditspipelineofimmune-basedcancerdru

          read more
          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more

          American taxpayers paid $1.8 trillion in health care costs in 2022

          AdobeAmericantaxpayersfootedthebillforatleast$1.8trillioninfederalandstatehealthcareexpendituresin20